Inhibitory effects of matrine, E-4031, dofetilide and RP58866 on inward rectifier potassium current in rabbit ventricular myocytes

Chinese Journal of Pharmacology and Toxicology

Volumn 18, Issue 6, 2004, Pages 407-414

  Yang, Bao Feng ^a,b   Li, Bao Xin ^a   Zhou, Yu Hong ^a   Dong, De Li ^a,b   Shan, Hong Li ^a   Wang, Ling ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Bio pharmaceutical Key Laboratory of Heilongjiang Province   (China)

Author keywords

Dofetilide; E 4031; Matrine; Myocardium; Patch clamp technique, whole cell; Potassium current, inward rectifier; RP58866

Indexed keywords

1 [2 (6 METHYL 2 PYRIDYL)ETHYL] 4 (4 METHYLSULFONYLAMINOBENZOYL)PIPERIDINE; DOFETILIDE; INWARDLY RECTIFYING POTASSIUM CHANNEL; MATRINE; TERIKALANT;

ANIMAL CELL; ANIMAL TISSUE; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; FEMALE; HEART MUSCLE CELL; HEART MUSCLE POTENTIAL; HEART VENTRICLE WALL; MALE; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; RABBIT;

EID: 14344266024     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Li Y, He LR. Pharmacological research of matrine in cardiovascular system[J]. Chin Tradit Herb Drugs, 2000, 31(3):227-229.
2. Jiang LF, Jiang YS. Pharmacological research of matrine [J]. Lishizhen Med Mat Med Res, 2000, 11(3):278-279.
3. + currents in mammalian ventricular myocytes[J]. Acta Pharmacol Sin, 1999, 20(11):961-969.
4. Ca, contributes to rate-dependent changes of action potentials in human ventricular myocytes[J]. Am J Physiol, 1999, 276(1 Pt 2):H98-H106.
5. Sanguinetti MC, Jurkiewicz NK, Scott A, Siegl PK. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action[J]. Circ Res, 1991, 68(1):77-84.
6. Wang HZ, Yang BF, Zhang LM, Xu DH, Wang ZG. Direct block of inward rectifier potassium channel by nicotine [J]. Toxicol Appl Pharmacol, 2000, 164:97-101.
7. Giles WR, Imaizumi Y. Comparison of potassium currents in rabbit atrial and ventricular cells[J]. J Physiol, 1988, 405:123-145.
8. K, and HERG channels of cardiac myocytes[J]. Acta Pharmacol Sin, 2001, 22(2):125-131.
9. + current in guinea pig ventricular myocytes[J] . Acta Pharmacol Sin, 1998, 19(3):269-272.
10. + currents in mammalian ventricular myocytes[J]. Asia Pac J Pharmacol, 1998, 13:9-17.
11. Kl[J]. J Mol Cell Cordial, 2001, 33(4); 625-638.
12. + currents in isolated human ventricular myocytes from patients with terminal heart failure[J]. Circ Res, 1993, 73 (2):379-385.
13. + channel in human cardiac myocytes. Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy[J] . Circulation, 1995, 92(2):164-174.
14. Boy den PA, Jeck CD. Ion channel function in disease[J]. Cardiovasc Res , 1995, 29(3):312-318.
15. Wilde AA, Aksnes G. Myocardial potassium loss and cell depolarisation in ischaemia and hypoxia[J]. Cardiovasc Res, 1995, 29(1):1-15.
16. Beaumont J, Michaels DC, Delmar M, Davidenko J, Jalife J. A model study of changes in excitability of ventricular muscle cells: inhibition, facilitation, and hysteresis[J]. Am J Physiol, 1995, 268(3 Pt 2):H1181-H1194.
17. Wang J, Feng J, Nattel S. Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide[J]. Circulation, 1994, 90(4):2032-2040.
18. Yang BF. Discussion in matter of Chinese antiarrhythmic herb[A]. In: Feng DS, Liao ZY, Wang YM, eds. Progress in Pharmacology Research [M]. Beijing: People's Medical Publishing House, 2002. 126-130.
19. Kiehn J, Villena P, Beyer T, Brachmann J. Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytes[J]. J Cardiovasc Pharmacol, 1994, 24(4):566-572.
20. Gwilt M, Arrowsmith JE, Blackburn KJ, Burges RA, Cross PE, Dalrymple HW, et al. UK-68798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells[J]. J Pharmacol Exp Ther, 1991, 256(1):318-324.
21. Martin CL, Chinn K. Contribution of delayed rectifier and inward rectifier to repolarization of the action potential: pharmacologic separation[J]. J. Cardiovasc Pharmacol, 1992, 19(5):830-837.